The ongoing debate about the surging demand for Hydroxychloroquine in the US, President Trump asking PM Modi for selling the HCQ drug and some controversies revolving around the statement made by the President in this context yesterday have led to lot of confusion. There has been rising concern about what stock piles of this drug is in India. Sandhya Sharma of ET Online speaks with Federation of Indian Export Organisation president, S K Saraf to get a clearer picture of the situation. Listen in!